Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.14M | -4.00M | -2.37M | -2.39M | -2.17M |
| Total Depreciation and Amortization | 1.00K | 1.00K | 1.00K | 2.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 278.00K | 315.00K | 274.00K | 113.00K | 51.00K |
| Change in Net Operating Assets | -176.00K | -316.00K | 17.00K | 192.00K | -425.00K |
| Cash from Operations | -4.04M | -4.00M | -2.08M | -2.09M | -2.54M |
| Capital Expenditure | -- | -- | 0.00 | -7.00K | -3.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 3.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 3.00K | 0.00 | -7.00K | -3.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 12.41M | 2.05M | 40.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | -30.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 12.41M | 2.02M | 40.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.04M | -4.00M | 10.33M | -70.00K | -2.50M |